Oxford Vacmedix

Oxford Vacmedix, a spin-off from the University of Oxford, is committed to developing cancer therapeutics based on the invention of recombinant overlapping peptides (ROP) by Dr. Songshi Jiang. These drugs represent an exciting new approach to immunotherapy, which is now a major focus in cancer treatment, making it more accessible, effective, and cost-efficient. Immunotherapy works by activating the immune system to directly attack tumors, thereby reducing the need for invasive treatments such as chemotherapy and radiotherapy.